Clinical trial Recruiting at 2 sites Interventional Ages 16 to 29

Identity-based therapy using virtual reality for young people with anxiety and depression

Official title: Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression: Engagement, Efficacy, and Predictors of Outcome

Run by University of Barcelona · NCT06384196 · Data updated 2026-11-12

This project tests a new identity-focused therapy that uses virtual reality to see if it helps young adults with anxiety and depression.

Quick facts

Study typeInterventional
Ages16 Years to 29 Years
SexAll
Enrollment138 (estimated)
SponsorUniversity of Barcelona
Academic / other
Locations2 sites (Badalona and 1 other locations)
StatusRecruiting
StartedMay 2, 2025
Main results expectedJune 30, 2027
Study endsNovember 2, 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT06384196 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adults whose primary problems are anxiety and/or depression, who can communicate in Spanish or Catalan and who do not have excluded comorbidities or contraindications to VR.

Probably not a fit

People with PTSD, bipolar disorder, substance use disorder, psychotic symptoms, significant suicidal ideation, major medical contraindications to VR (including epilepsy or certain cardiovascular conditions), pregnancy, or substantial sensory or cognitive deficits are unlikely to benefit or to be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares Identity-Based Transdiagnostic Therapy (IBTT), a youth-tailored psychotherapy that uses the EYME virtual reality platform to explore self-identity, with a standardized transdiagnostic approach (Unified Protocol). IBTT combines constructivist techniques and immersive VR to increase engagement and target shared emotional processes across anxiety and depression. Participants are young adults with primary symptoms of anxiety and/or depression and will receive structured psychological treatment at participating centers. Outcomes will include symptom change and measures of treatment engagement and acceptability.

Why it matters

Potential benefit: If successful, the approach could improve symptoms and increase engagement in therapy for young adults with anxiety and depression by using immersive identity-focused work.

How similar studies have gone: Transdiagnostic CBT approaches such as the Unified Protocol have demonstrated effectiveness, and VR-based therapies show promising results for some conditions, but combining identity-focused therapy with VR for young adults is a novel, still-unproven approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Participants with symptoms of depression and/or anxiety as their primary complaint.

Exclusion Criteria:

* Participants with post-traumatic stress, bipolar and substance use disorders, psychotic symptoms, organic brain dysfunction, marked suicidal ideation and/or intellectual disability.
* Participants receiving psychological treatment, unless it is suspended at the time of inclusion in the study itself in agreement with their therapist.
* Participants for whom the use of virtual reality may pose a risk, even a minor risk (epilepsia, acute otorhinolaryngological processes or recent interventions, severe cardiovascular disease, unstable hypertension, and pregnancy).
* Participants with substantial visual, hearing, and cognitive deficits.
* Participants who do not have enough competence to communicate in Spanish or Catalan.

Where it's running

  • Badalona Serveis Assistencials
    Badalona, Spain
    Recruiting
  • Associació Centre Higiene Mental Nou Barris
    Barcelona, Spain
    Recruiting

Study contacts

  • Principal investigator: Guillem Feixas, PhD — University of Barcelona
  • Study coordinator: Guillem Feixas, PhD
  • Email: gfeixas@ub.edu
  • Phone: +34933125100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.